Atlas Molecular Pharma cierra una ronda de 3 millones de euros liderada por Inveready para avanzar el desarrollo clínico de su primer candidato

by Inveready

Atlas Molecular Pharma (Atlas), creada con el objetivo de desarrollar nuevas chaperonas farmacológicas para el tratamiento de enfermedades metabólicas raras, ha completado su una ronda de financiaci...

Read more

CIC bioGUNE, CRB Inverbío, Kereon Partners and private investors create Atlas Molecular Pharma to discover new drugs for the treatment of Rare and Ultra-Rare diseases

by CRB Inverbío SA SGECR

The new company, Atlas Molecular Pharma, will further develop its proprietary technology to act as a “drug discovery engine” for the discovery and development of drugs called pharmacological chape...

Read more
Subscribe to Directory
Write an Article

Highlight

Axon moves into Cloud Technology

by Axon Partners Group

cloud technology axon

Axon has exited Captronic, the latest in...

by Axon Partners Group

Axon has exited Captronic Systems, an Indian company that develops tes...

Photos Stream